FindMyKOL
Clinical trialNCT02587351TerminatedPhase 3Interventional

Beta-Blockers for the Prevention of Acute Exacerbations of Chronic Obstructive Pulmonary Disease

SponsorUniversity of MinnesotaEnrollment532Pulmonary Disease, Chronic Obstructive
View the registry record on ClinicalTrials.gov

Summary

The lay summary the sponsor registered on ClinicalTrials.gov.

This is a multicenter, prospective, randomized, double-blind, placebo-controlled trial that will enroll 1028 patients with at least moderately severe COPD over a three year period and follow them at regular intervals for one year. The primary endpoint is time to first acute exacerbation. Secondary endpoints include rates and severity of COPD exacerbations, cardiovascular events, all-cause mortality, lung function, dyspnea, quality of life and metoprolol-related side effects.

Investigators

The overall officials registered on this study. Names that resolve to a FindMyKOL profile link to it; the rest are shown as registered.

A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.

Sites

27 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.

United States
  • Birmingham, Alabama Va Medical

    Birmingham, Alabama, United States

  • University of Alabama at Birmingham

    Birmingham, Alabama, United States

  • University of California, San Francisco-Fresno

    Fresno, California, United States

  • la Biomed at Harbor-Ucla Medical Center

    Los Angeles, California, United States

  • University of California at San Francisco

    San Francisco, California, United States

  • National Jewish Medical & Research Center

    Denver, Colorado, United States

  • North Florida/south Georgia Veterans Health System

    Gainesville, Florida, United States

  • Northwestern University

    Chicago, Illinois, United States

  • Louisiana State University

    New Orleans, Louisiana, United States

  • University of Maryland Baltimore

    Baltimore, Maryland, United States

  • Brigham and Women'S Hospital

    Boston, Massachusetts, United States

  • University of Michigan

    Ann Arbor, Michigan, United States

  • Va Ann Arbor Healthcare System

    Ann Arbor, Michigan, United States

  • Healthpartners Research Foundation

    Minneapolis, Minnesota, United States

  • Veteran'S Administration Medical Center

    Minneapolis, Minnesota, United States

  • Mayo Clinic

    Rochester, Minnesota, United States

  • Newyork-Presbyterian Brooklyn Methodist Hospital

    Brooklyn, New York, United States

  • New York Presbyterian/queens

    Flushing, New York, United States

  • Cornell University

    Ithaca, New York, United States

  • Columbia University

    New York, New York, United States

  • Cincinnati Va Medical Center

    Cincinnati, Ohio, United States

  • Cleveland Clinic

    Cleveland, Ohio, United States

  • Temple University Lung Center

    Philadelphia, Pennsylvania, United States

  • University of Pittsburgh

    Pittsburgh, Pennsylvania, United States

  • University of Utah Health Sciences Center

    Salt Lake City, Utah, United States

  • the University of Vermont

    Burlington, Vermont, United States

  • University of Washington School of Medicine

    Spokane, Washington, United States

Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.

Drugs studied

The drug and biological interventions registered on this study, normalized to their RxNorm ingredient where possible.

Linked drugs open the directory filtered to KOLs working with them.clinicaltrials.gov ↗

Registration & key dates

Registry attributes as recorded on the ClinicalTrials.gov study record.

Start
1 May 2016
Primary completion
1 Sept 2019
Completion
1 Dec 2019
Last update posted
25 Jan 2021
Registered enrollment
532
Registry id
NCT02587351

Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 11 Nov 2026. Registry facts are shown as registered by the study sponsor; FindMyKOL does not interpret them.